BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1719338)

  • 21. Noonan's syndrome: abnormalities of the growth hormone/IGF-I axis and the response to treatment with human biosynthetic growth hormone.
    Ahmed ML; Foot AB; Edge JA; Lamkin VA; Savage MO; Dunger DB
    Acta Paediatr Scand; 1991 Apr; 80(4):446-50. PubMed ID: 2058394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment.
    Mandel S; Moreland E; Nichols V; Hanna C; Lafranchi S
    J Clin Endocrinol Metab; 1995 Jan; 80(1):190-4. PubMed ID: 7530256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis.
    Holt RI; Simpson HL; Sönksen PH
    Diabet Med; 2003 Jan; 20(1):3-15. PubMed ID: 12519314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone-IGF-I axis and growth velocity in Chinese children with type 1 diabetes mellitus.
    Li G; Mick G; Wang X; Xue J; McCormick K
    J Pediatr Endocrinol Metab; 2006 Nov; 19(11):1313-8. PubMed ID: 17220059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus.
    Bereket A; Lang CH; Wilson TA
    Horm Metab Res; 1999; 31(2-3):172-81. PubMed ID: 10226799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of alternate-day or daily prednisone treatment on GH and cortisol levels in growth-retarded children after renal transplantation.
    Hokken-Koelega AC; de Muinck Keizer-Schrama SM; Drop SL
    J Pediatr Endocrinol; 1994; 7(2):119-25. PubMed ID: 7520318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I.
    Longo N; Singh R; Griffin LD; Langley SD; Parks JS; Elsas LJ
    J Clin Endocrinol Metab; 1994 Sep; 79(3):799-805. PubMed ID: 8077364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 concentrations in children with sickle cell disease.
    Soliman AT; el Banna N; alSalmi I; De Silva V; Craig A; Asfour M
    Metabolism; 1997 Nov; 46(11):1241-5. PubMed ID: 9361679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential regulation of insulin-like growth factor-(IGF) I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cells.
    Auernhammer CJ; Fottner C; Engelhardt D; Bidlingmaier M; Strasburger CJ; Weber MM
    Horm Res; 2002; 57(1-2):15-21. PubMed ID: 12006714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study.
    Allen DB
    J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone secretion in poorly growing children with renal hypophosphataemic rickets.
    Saggese G; Baroncelli GI; Bertelloni S; Perri G
    Eur J Pediatr; 1994 Aug; 153(8):548-55. PubMed ID: 7957399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of timing of growth hormone administration on plasma growth-hormone-binding activity, insulin-like growth factor-I and growth in children with a subnormal spontaneous secretion of growth hormone.
    Zadik Z; Lieberman E; Altman Y; Chen M; Limoni Y; Landau H
    Horm Res; 1993; 39(5-6):188-91. PubMed ID: 8314201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of renal failure on the growth hormone-insulin-like growth factor axis.
    Powell DR
    J Pediatr; 1997 Jul; 131(1 Pt 2):S13-6. PubMed ID: 9255220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of growth hormone secretion and action in growth-retarded children with juvenile chronic arthritis (JCA).
    Tsatsoulis A; Siamopoulou A; Petsoukis C; Challa A; Bairaktari E; Seferiadis K
    Growth Horm IGF Res; 1999 Apr; 9(2):143-9. PubMed ID: 10373347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.